Company intelligence / Profile preview

ICROM

Concorezzo, Lombardia, Italyicrom.com ↗

Ownership: Private
Employees: ~73
Development stage: Commercial

Overview

ICROM provides custom development and GMP manufacturing of complex small molecule APIs—including high-potency compounds—for global pharmaceutical clients. The company has invested heavily in expanding its R&D and manufacturing capacity with state-of-the-art facilities supporting both clinical-scale and commercial production. It recently acquired Holodiag SAS to expand into solid-state/crystallization services.

Therapeutic areas: Other
Modalities: Small moleculesHigh-potency APIsDiagnostic dyes and colored APIsBiocatalysisFlow chemistryHigh-potency APIs including ADCs (antibody-drug conjugates)
Industry: Contract Manufacturing Organization

Partnerships

No specific major pharma partnerships disclosed publicly; serves >40 countries globally as a CDMO partner to pharma companies large and small.

Beyond the preview

Go deeper on ICROM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICROM.

Explore the full profile